Delaware, US-based agriculture company Corteva, Inc. (NYSE: CTVA) has invested in Israel-based Lavie Bio, an agriculture biologicals subsidiary of biotechnology company Evogene Ltd., (NASDAW: EVGN) (TASE: EVGN), the company said.
The transaction includes the exchange of all shares of Corteva's wholly owned subsidiary Taxon Biosciences along with an equity investment by Corteva in Lavie. As consideration for the Taxon Biosciences shares and equity investment, Corteva will be issued approximately 30% of Lavie's equity while Evogene will hold approximately 70% of Lavie's equity.
SEGRO TO SELL UK BIG BOX WAREHOUSE PORTFOLIO FOR GBP 241M
RIVERSTONE ENERGY SELLS GULF OF MEXICO ASSETS TO TALOS ENERGY
RENEWABLES INFRASTRUCTURE GROUP ACQUIRES STAKE IN GERMAN OFFSHORE WIND PROJECT
NAKED WINES CLOSES SALE OF MAJESTIC WINE RETAIL OPERATION
KINDER MORGAN CANADA WINS SHAREHOLDER NOD FOR PEMBINA PIPELINE DEAL
GENERATIONAL EQUITY ADVISES FIELD SERVICE INDSTRY TECH SUPPLIER NCG IN SALE TO JONAS SOFTWARE
ELANCO ANIMAL HEALTH RECEIVES SECOND REQUEST FROM FTC REGARDING MERGER
BOXWOOD MERGER TO ADJOURN SPECIAL MEETING UNTIL 9 JANUARY AS COMPANY SEEKS FUNDING
BAYSWATER RESOURCES FUND III, YORK TACTICAL ENERGY FUND FORM JV FOR DJ BASIN DEVELOPMENT PROGRAMME
´GO SHOP´ PERIOD EXPIRES IN USD 5.4BN APOLLO ACQUISITION OF TECH DATA